Dose Escalated Simultaneous Integrated Boost Versus Standard Palliative Radiotherapy for Bone Metastases: A Comparative Analysis
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S156
DOI: 10.1016/j.ijrobp.2026.06.244 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von P. Rathod und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rathod, P., Talapatra, K., Mukherjee, U., S, A., Parab, A., Singh, A., & Sawant, M. (2026). Dose Escalated Simultaneous Integrated Boost Versus Standard Palliative Radiotherapy for Bone Metastases: A Comparative Analysis. International Journal of Radiation Oncology*Biology*Physics, 126(1), S156. https://doi.org/10.1016/j.ijrobp.2026.06.244
Vancouver
Rathod P, Talapatra K, Mukherjee U, S A, Parab A, Singh A, et al. Dose Escalated Simultaneous Integrated Boost Versus Standard Palliative Radiotherapy for Bone Metastases: A Comparative Analysis. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S156. doi:10.1016/j.ijrobp.2026.06.244
BibTeX
@article{Rathod2026,
author = {Rathod, P. and Talapatra, K. and Mukherjee, U. and S, A. and Parab, A. and Singh, A. and Sawant, M.},
title = {Dose Escalated Simultaneous Integrated Boost Versus Standard Palliative Radiotherapy for Bone Metastases: A Comparative Analysis},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S156},
doi = {10.1016/j.ijrobp.2026.06.244}
}
EUVIMED